Michael Aigner

Michael Aigner is a biologist, who studied Biology at the University Regensburg, Bavaria, Germany and holds a PhD in medical Microbiology from the University Hospital Regensburg. In 2008, he moved to the University hospital in Erlangen, Germany and focused on adoptive T cell therapy. After first clinical trials with antigen-specific T cells in malignant melanoma and multi-virus specific T cells for prevention and treatment of virus reactivation after allogenic SCT, he established one of the first academic GMP laboratories for manufacturing of CAR T cells in Germany. He and his teams have produced CAR T and TRUCK cell products for over 100 patients in a wide variety of indications, including the world first CAR T products for patients with systemic Lupus erythematosus, systemic sclerosis, autoimmune myositis and ulcerative colitis. Dr. Aigner is a member of the medical faculty in Erlangen, the German national Specialized Ethics Committee for Special Procedures, Germany National Strategy